Inflammatory Bowel Diseases (IBD): Clinical Trials

1 trial for Inflammatory Bowel Diseases (IBD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Not yet recruiting 1
Phase 21Not yet recruiting 1

Follow Inflammatory Bowel Diseases (IBD): new trials by email Literature Review of Inflammatory Bowel Diseases (IBD) trials Research Report on Inflammatory Bowel Diseases (IBD)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BCMA-CD19 cCAR T for the Treatment of Refractory Inflammatory Bowel Disease (IBD)
ICG318, BCMA-CD19-IL-15/IL-15 sushi Compound CAR T - Inflammatory Bowel Diseases (IBD)
Phase 1 / Phase 2Not yet recruitingiCell Gene Therapeutics182026-04-072026-04-22

Narrower conditions

Colitis, Ulcerative (1)  ·  Crohn Disease (1)  ·  Inflammatory Bowel Diseases (1)

Broader conditions

Colitis (1)  ·  Colonic Diseases (1)  ·  Digestive System Diseases (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)  ·  Intestinal Diseases (1)

Sponsors

iCell Gene Therapeutics (1)

Countries

China (1)